A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes (NCT07743450)
A Phase III, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Once-Daily Oral ASC30 in Adult Participants With Obesity or Overweight With Type 2 Diabetes Mellitus (AURORA-2)
🩺 Plain-English Summary (8th-Grade Level)
Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight and T2DM.
Who can join: Review the eligibility criteria below.
Location: AURORA-2 Clinical Site — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (136 Sites)
Showing the first 25 of 136 sites.
- AURORA-2 Clinical Site — Birmingham, Alabama
- AURORA-2 Clinical Site — Huntsville, Alabama
- AURORA-2 Clinical Site — Peoria, Arizona
- AURORA-2 Clinical Site — Phoenix, Arizona
- AURORA-2 Clinical Site — Tempe, Arizona
- AURORA-2 Clinical Site — Tucson, Arizona
- AURORA-2 Clinical Site — Little Rock, Arkansas
- AURORA-2 Clinical Site — Banning, California
- AURORA-2 Clinical Site — Chula Vista, California
- AURORA-2 Clinical Site — Covina, California
- AURORA-2 Clinical Site — Gardena, California
- AURORA-2 Clinical Site — La Mesa, California
- AURORA-2 Clinical Site — Los Angeles, California
- AURORA-2 Clinical Site — Sacramento, California
- AURORA-2 Clinical Site — Tarzana, California
- AURORA-2 Clinical Site — Tustin, California
- AURORA-2 Clinical Site — Washington D.C., District of Columbia
- AURORA-2 Clinical Site — Boca Raton, Florida
- AURORA-2 Clinical Site — Daytona Beach, Florida
- AURORA-2 Clinical Site — Jacksonville, Florida
- AURORA-2 Clinical Site — Leesburg, Florida
- AURORA-2 Clinical Site — Melbourne, Florida
- AURORA-2 Clinical Site — South Miami, Florida
- AURORA-2 Clinical Site — Tampa, Florida
- AURORA-2 Clinical Site — The Villages, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity
- Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools — Tampa, Florida
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity — Tucson, Arizona
- Piloting a Patient Navigator Program for Weight Loss — Philadelphia, Pennsylvania
- Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) — Mesa, Arizona
- Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects — Orlando, Florida
- Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans — Pittsburgh, Pennsylvania
Explore by condition: All Obesity clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.